LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Asymptomatic Individuals May Shed Infective Leptospira Bacteria in Their Urine

By LabMedica International staff writers
Posted on 09 Mar 2016
Image: Scanning electron micrograph of Leptospira sp. Bacteria (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).
Image: Scanning electron micrograph of Leptospira sp. Bacteria (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).
An international team of molecular microbiologists has assembled a comprehensive, cross-species genomic comparison of all 20 known species of Leptospira and determined that a pool of asymptomatic individuals was shedding the bacteria in their urine.

The more than 200 types of spiral-shaped bacteria (spirochetes) in the genus Leptospira are classified as pathogenic, intermediately pathogenic, or saprophytic based on their ability to cause disease and on genetic information.

In humans, approximately 90% of cases of the disease are mild leptospirosis. Others experience a severe form of the disease known as Weil's disease, which is characterized by liver damage (causing jaundice), kidney failure, and bleeding. Additionally, the heart and brain can be affected; meningitis of the outer layer of the brain, encephalitis of brain tissue with same signs and symptoms; and lung affected as the most serious and life-threatening of all leptospirosis complications. The infection is often incorrectly diagnosed due to the nonspecific symptoms.

An international team of molecular microbiologists sought evidence for human reservoirs of the bacteria and for genetic clues as to why it caused such a broad range of symptoms among infected individuals. The investigators from the United States, Australia, France, England, The Netherlands, Canada, Uruguay, Brazil, Peru, and Thailand used a combination of epidemiological data, serology, and molecular detection of the leptospiral 16S rRNA gene to identify asymptomatic urinary shedders of Leptospira among the inhabitants of a rural village in the Peruvian Amazon region.

They reported in the February 23, 2016, online edition of the journal PLOS Neglected Tropical Diseases that approximately one-third of 314 asymptomatic participants had circulating anti-leptospiral antibodies. Among enrolled participants, 189 (59%) had evidence of recent infection. Among these people, 13 (all women) had Leptospira DNA-positive urine samples. A group of 102 long-term asymptomatic individuals without serological evidence of recent infection was identified. Within this group, six (5.9%) excreted pathogenic and intermediate-pathogenic Leptospira in their urine.

The results showed that asymptomatic renal colonization of Leptospira bacteria in a region of high disease transmission was common, including among people without serological or clinical evidence of recent infection. Both pathogenic and intermediate Leptospira could persist as renal colonization in humans.

Leptospira is the most complex genus of bacteria that infects humans,” said senior author Dr. Joseph M. Vinetz, professor of medicine at the University of California, San Diego (USA). “This work compares the complete genome sequences of all known species of Leptospira to discover which genes make this bacterium a pathogen. It provides a roadmap for future research, including finding new ways to diagnose infection and vaccine development.”

“One fascinating finding was discovering the CRISPR-Cas genetic machinery only in pathogenic Leptospira, but not in the intermediate or non-infectious groups of the genus. The evolutionary acquisition of novel CRISPR elements, which are only in pathogenic Leptospira, probably hastened adaptation to human infection. The significance of this observation remains to be explored,” said Dr. Vinetz.

Related Links:

University of California, San Diego


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more